Back to Search
WILLIAM STANLEY, MD
MD
Addiction Medicine (Internal Medicine) Physician
NPI: 1730128513Individual
Specialties, Licenses & Credentials
Addiction Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Addiction Medicine
Code: 207RA0401X
C153751(CA)
Research & Publications (20)
Myocardial substrate metabolism in the normal and failing heart.
PMID 15987803·Physiol Rev·2005
6-review
Ranolazine: new approach for the treatment of stable angina pectoris.
PMID 16181027·Expert Rev Cardiovasc Ther·2005
6-review
Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.
PMID 16583175·Heart Fail Rev·2005
6-review
Rationale for a metabolic approach in diabetic coronary patients.
PMID 16340398·Coron Artery Dis·2005
6-review
Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.
PMID 16100246·Am J Physiol Heart Circ Physiol·2005
7-preclinical
Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies.
PMID 15378130·J Cardiovasc Pharmacol Ther·2004
6-review
beta-Hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content.
PMID 12969881·Am J Physiol Heart Circ Physiol·2003
7-preclinical
Post-ischemic treatment with dipyruvyl-acetyl-glycerol decreases myocardial infarct size in the pig.
PMID 14574079·Cardiovasc Drugs Ther·2003
7-preclinical
Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
PMID 12667223·Fundam Clin Pharmacol·2003
6-review
Partial fatty acid oxidation inhibitors for stable angina.
PMID 11996644·Expert Opin Investig Drugs·2002
6-review
Introduction to special issue on myocardial energy metabolism in heart failure.
PMID 11988635·Heart Fail Rev·2002
7-preclinical
Energy metabolism in the normal and failing heart: potential for therapeutic interventions.
PMID 11988636·Heart Fail Rev·2002
6-review
Cardiac energetics during ischaemia and the rationale for metabolic interventions.
PMID 11286306·Coron Artery Dis·2001
6-review
Diabetes reduces right atrial beta-adrenergic signaling but not agonist stimulation of heart rate in swine.
PMID 11332512·Can J Physiol Pharmacol·2001
7-preclinical
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH.
PMID 19429815·Am J Physiol Heart Circ Physiol·2009
7-preclinical
omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential.
PMID 19474179·Cardiovasc Res·2009
6-review
Effects of exercise training and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance.
PMID 19531640·Am J Physiol Endocrinol Metab·2009
2-rct
The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: role of cardiac phospholipid remodeling.
PMID 19597033·Hypertension·2009
7-preclinical
Altered expression of the adenine nucleotide translocase isoforms and decreased ATP synthase activity in skeletal muscle mitochondria in heart failure.
PMID 19233197·J Mol Cell Cardiol·2009
7-preclinical
Chronic treatment with the peroxisome proliferator-activated receptor alpha agonist Wy-14,643 attenuates myocardial respiratory capacity and contractile function.
PMID 19360380·Mol Cell Biochem·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 23661 PACIFIC COAST HWY # B
MALIBU, CA 90265 - Phone
- (310) 341-0188
Quick Facts
- NPI
- 1730128513
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile